Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies

Journal of Immunology Research
Shangjun SunYang Fu

Abstract

T cells modified via chimeric antigen receptors (CARs) have emerged as a promising treatment modality. Unparalleled clinical efficacy recently demonstrated in refractory B-cell malignancy has brought this new form of adoptive immunotherapy to the center stage. Nonetheless, its current success has also highlighted its potential treatment-related toxicities. The adverse events observed in the clinical trials are described in this review, after which, some innovative strategies developed to overcome these unwanted toxicities are outlined, including suicide genes, targeted activation, and other novel strategies.

References

Aug 3, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·D ChalmersM Garin
Feb 25, 2005·Blood·Karin C StraathofCliona M Rooney
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cor H J LamersEgbert Oosterwijk
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael H KershawPatrick Hwu
Aug 9, 2008·The Journal of Clinical Investigation·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Sep 8, 2009·Haematologica·Marieke GriffioenMirjam H M Heemskerk
Mar 23, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael C JensenStephen J Forman
May 19, 2010·Expert Review of Clinical Immunology·Peter J BugelskiEsther Bouman-Thio
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John H SampsonDarell D Bigner
May 13, 2011·The New England Journal of Medicine·Scott C HowardChing-Hon Pui
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Nov 4, 2011·The New England Journal of Medicine·Antonio Di StasiMalcolm K Brenner
Jan 21, 2012·The Journal of Gene Medicine·Kevin J CurranRenier J Brentjens
May 4, 2012·Science Translational Medicine·John SchollerCarl H June
Sep 22, 2012·Nature Reviews. Cancer·Luca GattinoniNicholas P Restifo
Oct 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Koji TamadaEduardo Davila
Dec 21, 2012·The New England Journal of Medicine·Fabrizio De BenedettiUNKNOWN PRCSG
Feb 21, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Cor Hj LamersJan W Gratama
Mar 27, 2013·The New England Journal of Medicine·Stephan A GruppCarl H June
Apr 5, 2013·Science Translational Medicine·Michael A FischbachWendell A Lim
May 8, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Jul 11, 2013·Molecular Therapy. Nucleic Acids·Zakaria GradaNabil Ahmed
Dec 18, 2013·Immunological Reviews·Gianpietro DottiMalcolm K Brenner
Dec 18, 2013·Science Translational Medicine·Victor D FedorovMichel Sadelain
Feb 21, 2014·Science Translational Medicine·Marco L DavilaRenier Brentjens

❮ Previous
Next ❯

Citations

May 22, 2019·Cells·Stefan StoiberSebastian Kobold
Aug 11, 2020·Frontiers in Cellular and Infection Microbiology·Ping-Hsien LeeCatherine M Bollard
Feb 7, 2020·Expert Opinion on Biological Therapy·Steven H ShenJohn H Sampson
Nov 13, 2020·Critical Reviews in Oncology/hematology·Stella Bouziana, Dimitrios Bouzianas
Oct 13, 2019·Seminars in Immunology·Jean-Philippe BastienDenis Claude Roy
Feb 14, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Barbara Blanco-FernandezElisabeth Engel
Oct 27, 2020·Oncoimmunology·Fernanda Pohl-GuimarãesDuane A Mitchell
Mar 7, 2021·International Journal of Molecular Sciences·Wan-Tai WuYi-Yen Lee
Jun 1, 2019·Current Opinion in Chemical Biology·Satoshi TodaWendell A Lim
Apr 4, 2021·International Journal of Molecular Sciences·Kento FujiwaraNaoki Okada
Apr 7, 2021·Expert Review of Clinical Immunology·Kajal ChaudhryCatherine M Bollard
Apr 7, 2021·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Neeraj Chhabra, Joseph Kennedy
May 22, 2021·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Yeison Santamaria-Alza, Gloria Vasquez
Sep 30, 2021·Journal of Cellular and Molecular Medicine·Xiaoyue CuiAijie Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

© 2022 Meta ULC. All rights reserved